Interferon Inducible IFI16 Expression in p16 Positive Squamous Cell Carcinoma of the Oropharynx

Figure 5

Cumulative prognostic value of stage IVA patients (Kaplan-Meier analysis). (a) p16 positive patients showed better prognosis (𝑃=0.014). (b) No difference was observed between IFI16 positive and negative patients (𝑃=0.757). (c and d) p16 negative patients exhibited worse prognosis in IFI16 positive ((c) 𝑃=0.046) group. No significant difference was observed in IFI16 negative ((d) 𝑃=0.157) group. Statistical analysis was performed using the log-rank test.

(a)

(b)

(c)

(d)